fbpx
01 / 05
New Vaccine Triggers Immune Response to Fight Brain Tumor

Medical Xpress | Vaccination

New Vaccine Triggers Immune Response to Fight Brain Tumor

“In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at the University of Florida quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor…

Reported May 1 in the journal Cell, the discovery represents a potential new way to recruit the immune system to fight notoriously treatment-resistant cancers using an iteration of mRNA technology and lipid nanoparticles, similar to COVID-19 vaccines, but with two key differences: use of a patient’s own tumor cells to create a personalized vaccine, and a newly engineered complex delivery mechanism within the vaccine.”

From Medical Xpress.

UNICEF | Vaccination

Zambia Launches Malaria Vaccine to Protect Half a Million Children

“The Government of the Republic of Zambia, through the Ministry of Health, today [10/27/25] officially launched the malaria vaccine – R21/Matrix-M,as part of its Expanded Programme on Immunisation (EPI), marking a historic milestone in the country’s fight against malaria. Over 500,000 children aged 6-8 months will be vaccinated in the months following the launch.

Zambia will be the 24th country to introduce the malaria vaccine.”

From UNICEF.

Science | Vaccination

Bonus from COVID-19 Vaccines: Bolstering Cancer Treatment

“Grippin and colleagues analyzed the records of more than 1000 patients who were treated for advanced skin and lung cancer at MD Anderson between 2019 and ’23. People who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy with checkpoint inhibitors lived significantly longer than those who received the same drugs but didn’t get the vaccine. For patients with advanced lung cancer, the median survival rate nearly doubled, rising from 20.6 months to 37.3.”

From Science.

The Independent | Vaccination

“Landmark” for Elephants After Vaccine Breakthrough

“An international team of vets has made a breakthrough in a vaccine trial for a virus that killed seven elephants at Chester Zoo.

Elephant endotheliotropic herpesvirus (EEHV) is a leading cause of death for young Asian elephants, both captive and wild, with no cure. Trials with adult elephants at Chester Zoo found a new vaccine safely triggered a strong immune response. The team (University of Surrey, Chester Zoo, Animal and Plant Health Agency) observed no side effects.”

From The Independent.